These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24395784)

  • 1. Lysine deacetylase inhibition prevents diabetes by chromatin-independent immunoregulation and β-cell protection.
    Christensen DP; Gysemans C; Lundh M; Dahllöf MS; Noesgaard D; Schmidt SF; Mandrup S; Birkbak N; Workman CT; Piemonti L; Blaabjerg L; Monzani V; Fossati G; Mascagni P; Paraskevas S; Aikin RA; Billestrup N; Grunnet LG; Dinarello CA; Mathieu C; Mandrup-Poulsen T
    Proc Natl Acad Sci U S A; 2014 Jan; 111(3):1055-9. PubMed ID: 24395784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The lysine deacetylase inhibitor Givinostat inhibits β-cell IL-1β induced IL-1β transcription and processing.
    Dahllöf MS; Christensen DP; Lundh M; Dinarello CA; Mascagni P; Grunnet LG; Mandrup-Poulsen T
    Islets; 2012; 4(6):417-22. PubMed ID: 23486342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs and histone deacetylase inhibition-mediated protection against inflammatory β-cell damage.
    Lindeløv Vestergaard A; Heiner Bang-Berthelsen C; Fløyel T; Lucien Stahl J; Christen L; Taheri Sotudeh F; de Hemmer Horskjær P; Stensgaard Frederiksen K; Greek Kofod F; Bruun C; Adrian Berchtold L; Størling J; Regazzi R; Kaur S; Pociot F; Mandrup-Poulsen T
    PLoS One; 2018; 13(9):e0203713. PubMed ID: 30260972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combination therapy with dipeptidyl peptidase-IV and histone deacetylase inhibitors in the non-obese diabetic mouse model of type 1 diabetes.
    Cabrera SM; Colvin SC; Tersey SA; Maier B; Nadler JL; Mirmira RG
    Clin Exp Immunol; 2013 Jun; 172(3):375-82. PubMed ID: 23600825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylases 1 and 3 but not 2 mediate cytokine-induced beta cell apoptosis in INS-1 cells and dispersed primary islets from rats and are differentially regulated in the islets of type 1 diabetic children.
    Lundh M; Christensen DP; Damgaard Nielsen M; Richardson SJ; Dahllöf MS; Skovgaard T; Berthelsen J; Dinarello CA; Stevenazzi A; Mascagni P; Grunnet LG; Morgan NG; Mandrup-Poulsen T
    Diabetologia; 2012 Sep; 55(9):2421-31. PubMed ID: 22772764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice.
    Besançon A; Goncalves T; Valette F; Dahllöf MS; Mandrup-Poulsen T; Chatenoud L; You S
    Diabetologia; 2018 Feb; 61(2):389-398. PubMed ID: 29030662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatin remodeling resets the immune system to protect against autoimmune diabetes in mice.
    Patel T; Patel V; Singh R; Jayaraman S
    Immunol Cell Biol; 2011 Jul; 89(5):640-9. PubMed ID: 21321581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors potentiate vesicular stomatitis virus oncolysis in prostate cancer cells by modulating NF-κB-dependent autophagy.
    Shulak L; Beljanski V; Chiang C; Dutta SM; Van Grevenynghe J; Belgnaoui SM; Nguyên TL; Di Lenardo T; Semmes OJ; Lin R; Hiscott J
    J Virol; 2014 Mar; 88(5):2927-40. PubMed ID: 24371063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitor suppresses virus-induced proinflammatory responses and type 1 diabetes.
    Hara N; Alkanani AK; Dinarello CA; Zipris D
    J Mol Med (Berl); 2014 Jan; 92(1):93-102. PubMed ID: 23982318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vorinostat Modulates the Imbalance of T Cell Subsets, Suppresses Macrophage Activity, and Ameliorates Experimental Autoimmune Uveoretinitis.
    Fang S; Meng X; Zhang Z; Wang Y; Liu Y; You C; Yan H
    Neuromolecular Med; 2016 Mar; 18(1):134-45. PubMed ID: 26798022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of histone deacetylases prevents cytokine-induced toxicity in beta cells.
    Larsen L; Tonnesen M; Ronn SG; Størling J; Jørgensen S; Mascagni P; Dinarello CA; Billestrup N; Mandrup-Poulsen T
    Diabetologia; 2007 Apr; 50(4):779-89. PubMed ID: 17265033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of glyceroneogenesis by histone deacetylase 3 contributes to lipodystrophy in mice with adipose tissue inflammation.
    Zhang J; Henagan TM; Gao Z; Ye J
    Endocrinology; 2011 May; 152(5):1829-38. PubMed ID: 21406501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice.
    Kim S; Millet I; Kim HS; Kim JY; Han MS; Lee MK; Kim KW; Sherwin RS; Karin M; Lee MS
    Proc Natl Acad Sci U S A; 2007 Feb; 104(6):1913-8. PubMed ID: 17267600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vorinostat, a HDAC inhibitor, showed anti-osteoarthritic activities through inhibition of iNOS and MMP expression, p38 and ERK phosphorylation and blocking NF-κB nuclear translocation.
    Zhong HM; Ding QH; Chen WP; Luo RB
    Int Immunopharmacol; 2013 Oct; 17(2):329-35. PubMed ID: 23856614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boswellic extracts and 11-keto-ß-boswellic acids prevent type 1 and type 2 diabetes mellitus by suppressing the expression of proinflammatory cytokines.
    Ammon HPT
    Phytomedicine; 2019 Oct; 63():153002. PubMed ID: 31301539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoform-selective inhibitor of histone deacetylase 3 (HDAC3) limits pancreatic islet infiltration and protects female nonobese diabetic mice from diabetes.
    Dirice E; Ng RWS; Martinez R; Hu J; Wagner FF; Holson EB; Wagner BK; Kulkarni RN
    J Biol Chem; 2017 Oct; 292(43):17598-17608. PubMed ID: 28860191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes.
    Jörns A; Arndt T; Meyer zu Vilsendorf A; Klempnauer J; Wedekind D; Hedrich HJ; Marselli L; Marchetti P; Harada N; Nakaya Y; Wang GS; Scott FW; Gysemans C; Mathieu C; Lenzen S
    Diabetologia; 2014 Mar; 57(3):512-21. PubMed ID: 24310561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inducible nitric oxide synthase (iNOS) in pancreatic islets of nonobese diabetic mice: identification of iNOS- expressing cells and relationships to cytokines expressed in the islets.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Bleackley RC
    Endocrinology; 1996 May; 137(5):2093-9. PubMed ID: 8612552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibition promotes osteoblast maturation by altering the histone H4 epigenome and reduces Akt phosphorylation.
    Dudakovic A; Evans JM; Li Y; Middha S; McGee-Lawrence ME; van Wijnen AJ; Westendorf JJ
    J Biol Chem; 2013 Oct; 288(40):28783-91. PubMed ID: 23940046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.
    Ashburner BP; Westerheide SD; Baldwin AS
    Mol Cell Biol; 2001 Oct; 21(20):7065-77. PubMed ID: 11564889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.